Mitochondrial fatty acid oxidation in obesity
Dolors Serra1, Paula Mera, Maria Ida Malandrino
1Department of Biochemistry and Molecular Biology, Facultat de Farmàcia, Universitat de Barcelona, Institut de Biomedicina de la Universitat de Barcelona IBUB, Barcelona, Spain.
Antioxidants & Redox Signaling
|August 21, 2012
Summary
Mitochondrial fatty acid oxidation (FAO) offers a promising new avenue for obesity treatment. Enhancing cellular energy expenditure through FAO may combat obesity and related health issues.
Area of Science:
- Metabolic research
- Obesity studies
- Mitochondrial function
Background:
- Current lifestyles promote obesity, leading to severe health issues like diabetes and hypertension.
- Traditional obesity treatments (diet, exercise) have limitations.
- Enhancing cellular energy expenditure is an emerging therapeutic strategy.
Purpose of the Study:
- To review novel anti-obesity strategies targeting mitochondrial fatty acid oxidation (FAO).
- To explore the potential of FAO as an alternative obesity therapy.
Main Methods:
- Review of recent discoveries on mitochondrial fatty acid oxidation (FAO).
- Focus on FAO's role in liver, muscle, and adipose tissue energy expenditure.
- Examination of FAO's involvement in hypothalamic appetite control.
Main Results:
- Mitochondrial FAO is a potential therapeutic target for obesity.
- Increased FAO in liver and muscle shows controversial benefits.
- Studies explore potentiating adipose tissue energy expenditure via FAO.
- Hypotheses link FAO and reactive oxygen species to appetite regulation.
Conclusions:
- Novel anti-obesity strategies targeting mitochondrial FAO are of significant future interest.
- Targeting mitochondrial FAO may help combat obesity-related disorders.
Related Concept Videos
01:28Overview of Fatty Acid Metabolism
Lipids also are sources of energy that power cellular processes. Like carbohydrates, lipids are composed of carbon, hydrogen, and oxygen, but these atoms are arranged differently. Most lipids are nonpolar and hydrophobic. Major types include fats and oils, waxes, phospholipids, and steroids.
Fatty acids are catabolized in a process called beta-oxidation, which takes place in the matrix of the mitochondria and converts their fatty acid chains into two-carbon units of acetyl groups. The acetyl...
Fatty acids are catabolized in a process called beta-oxidation, which takes place in the matrix of the mitochondria and converts their fatty acid chains into two-carbon units of acetyl groups. The acetyl...
01:24Overview of Lipid Metabolism
Lipid metabolism is a crucial process in the human body that involves the synthesis and degradation of lipids. This process is essential for energy production, cell membrane formation, and hormone production, among other functions.
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
01:24Obesity
The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in adipocytes...
01:20Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion
Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
01:15Pyruvate Oxidation
After glycolysis, the charged pyruvate molecules enter the mitochondria via active transport and undergo three enzymatic reactions. These reactions ensure that pyruvate can enter the next metabolic pathway so that energy stored in the pyruvate molecules can be harnessed by the cells.
First, the enzyme pyruvate dehydrogenase removes the carboxyl group from pyruvate and releases it as carbon dioxide. The stripped molecule is then oxidized and releases electrons, which are then picked up by NAD+...
First, the enzyme pyruvate dehydrogenase removes the carboxyl group from pyruvate and releases it as carbon dioxide. The stripped molecule is then oxidized and releases electrons, which are then picked up by NAD+...
01:06Fats as Energy Storage Molecules
Triglycerides are a form of long-term energy storage molecules. They are made of glycerol and three fatty acids. To obtain energy from fat, triglycerides must first be broken down by hydrolysis into their two principal components, fatty acids and glycerol. This process, called lipolysis, takes place in the cytoplasm. The resulting fatty acids are oxidized by β-oxidation into acetyl-CoA, which is used by the Krebs cycle. The glycerol that is released from triglycerides after lipolysis directly...